Bigfoot is real. That’s according to a group of Colorado researchers who say they have hard evidence proving its existence.
Researcher Dave Paulides is convinced the reality of Bigfoot isn’t as fuzzy as the photos from people who claim to have seen the mythological creature.
“This DNA is like nothing else in the world,” Paulides said.
Paulides says Bigfoot looks approximately 7 to 8 feet tall and weighs in at a whopping 800 to 1,000 pounds.
“It’s easy to say a lot of things are crazy. If you lived underground your whole life, the belief that 400 people could fly in a plane would sound crazy,” Paulides said.
Paulides says his research group has collected hundreds of samples of DNA evidence. He focused his search in Northern California’s redwoods. He says strands of hair are from a Sasquatch, genetically tested to reveal a previously unknown species.
Not a single research institution in the country has confirmed the DNA test results, but Paulides says there are thousands of sightings a year, from California to Tennessee, including dozens in Colorado.
“Colorado Parks and Wildlife does not currently list ‘Sasquatch,’ ‘Yeti,’ ‘Bigfoot,’ ‘The Abominable Snowman,’ or ‘Harry’ (of ‘Harry and the Hendersons’) as any of the more than 900 diverse species that are native to Colorado,” the organization said in a statement.
“I think that the government probably is aware of the subject, but it’s difficult to give acknowledgement to something that they obviously can’t control,” Paulides said.
Paulides says he’s surprised more people haven’t seen Bigfoot. He believes there could be as many as 50,000 in the wilderness.
Categories: Uncategorized Tags: bigfoot, bigfoot dna, bigfoot real, breeding, Complete Genomics Analysis Platform, Complete Genomics Initial Public Offering, decide, genetics, genome-based research, Homosapien, Human Genome, whole genome sequencing
The genes, BRCA1 and BRCA2, have been associated with hereditary forms of breast and ovarian cancer. The plaintiffs argue that Myriad Genentics’ patent hinders potentially life-saving cancer research and patient access to diagnostic testing. They are also pushing for the courts to recognize genes as “products of nature” and, therefore, unpatentable.
Conversely, Myriad argues that they do not own the patent on the gene itself; rather, they own the patent on the process for isolating the gene. The company also argues that patents on genes create a financial incentive for companies to fund genetic research.
The plaintiffs include genetic counselors and researchers, patients, cancer and women’s health organizations, and medical professional organizations.
Lisbeth Ceriani, a breast cancer survivor and plaintiff in the case, had to pay Myriad over $4,000 to receive genetic testing to see if her breast cancer was hereditary. “Women should not have to go through what I went through in order to take care of themselves and continue to take care of their families,” said Ceriani. “My genes belong to me. Knowledge about my own body should not be held hostage by a corporation.”
A federal patent court invalidated the patents in 2010. However, the United States Court of Appeals for the Federal Circuit (CAFC) has upheld the patent twice, even after they were ordered to reconsider their ruling in light of the Supreme Court’s decision in Prometheus Laboratories v. Mayo Collaborative Services, which held that the patenting of certain medical diagnostics was unconstitutional.
“It’s wrong to think that something as naturally occurring as DNA can be patented by a single company that limits scientific research and the free exchange of ideas,” said Chris Hansen, my personal hero, and staff attorney with the ACLU Speech, Privacy and Technology Project . “The Court of Appeals failed to consider the Supreme Court’s most recent ruling on patent law.”
The basis for patent law in the Constitution lies in Article I, Section 8, which says, “Congress has the power…to promote the progress of science and useful arts, by securing for limited times to authors and inventors the exclusive right to their respective writings and discoveries.” Congress has delegated to the federal patent courts the responsibility to implement this power.